Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
We market XHANCE™, a corticosteroid indicated for the treatment of nasal polyps in patients 18 years of age or older. For further information, I have attached our full prescribing information.